Drug
Iohexol
Iohexol: highest development phase Post-Market, developed by Guerbet. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Guerbet
Trials
| Drug | Phase | Indication |
|---|---|---|
| Iohexol NCT03631771 | Post-Market | Hypothyroidism |
Latest
No recent events.
Follow Iohexol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.